CD40 antibody formulation and methods

Details for Australian Patent Application No. 2004308749 (hide)

Owner Pfizer Products Inc.

Inventors Cusmano, John Daniel; Bedian, Vahe; Gladue, Ronald Paul

Agent Allens Arthur Robinson

Pub. Number AU-B-2004308749

PCT Pub. Number WO2005/063289

Priority 60/531,639 22.12.03 US

Filing date 9 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 28 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063289 Priority application(s): WO2005/063289

28 October 2010 Application Accepted

  Published as AU-B-2004308749

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308756-Gas-filled microvesicle assembly for contrast imaging

2004308747-Pregabalin composition